 |
|
|
|
 |
|
|
|
| Article 1 to 10 out of 1129
|
|
-
Oncothyreon to receive milestone payment from Merck KGaA
(16 May 2008)
Oncothyreon Inc. announced that it has completed the transfer of certain assays and manufacturing technology related to Stimuvax(R) (BLP25 liposome vaccine) to Merck KGaA of Darmstadt, Germany, triggering a payment to Oncothyreon of $3 million. ......
-
Families shed light on likely causative gene for Alzheimer's
(16 May 2008)
The genetic profile of two large Georgia families with high rates of late-onset Alzheimer's disease points to a gene that may cause the disease, researchers say. Genetic variations called single nucleotide polymorphisms, or SNPs, are common in ......
-
Novosom granted US and European patents for RNAi-delivering Smarticles
(16 May 2008)
Novosom AG announced that it has been granted patents for both the USA and Europe for its Drug Delivery technology SmarticlesŪ. SmarticlesŪ are fully charge reversible liposomes for the in vivo drug delivery of nucleotides like siRNA or ......
-
Intercell AG to acquire Iomai Corporation to expand late stage product pipeline and strengthen leadership in vaccine innovation
(14 May 2008)
Intercell AG and Iomai Corporation announced that they have entered into a definitive agreement pursuant to which Intercell will acquire Iomai for USD 6.60 per share representing a fully diluted equity value of approximately USD 189 million ......
-
NicOx announces initiation of first phase 1 study of investigational nitric oxide-donating agent in hypertensive patients
(14 May 2008)
NicOx S.A. announced that Merck & Co., Inc. has initiated the first in a series of planned clinical studies, in mild to moderate hypertensive patients, under the companies' collaborative agreement to develop new nitric oxide-donating ......
-
FivePrime Reports Discovery of IL-34
(13 May 2008)
Science, researchers at Five Prime Therapeutics, Inc. report the discovery of Interleukin34, a novel cytokine, as well as the identification of an IL-34 receptor. "This work is a textbook example of how our platform enables us to make important ......
-
Berkeley Researchers Identify Photosynthetic Dimmer Switch
(13 May 2008)
In a study of the molecular mechanisms by which plants protect themselves from oxidation damage should they absorb too much sunlight during photosynthesis, a team of researchers has discovered a molecular "dimmer switch" that helps control the ......
-
Platypus genome reveals evolutionary path that gave mammals reproductive edge
(09 May 2008)
The odd-looking platypus is often cited as proof that God has a sense of humor. Now researchers at the Stanford University School of Medicine have turned to the strange animal to understand the genesis of an evolutionary tour de force that led ......
-
Agilent Technologies Expands Therapeutic Nucleic Acids Manufacturing Capacity
(09 May 2008)
Dow Nucleic Acids Medicines Business Assets Acquired
Agilent Technologies Inc. announced the expansion of its nucleic acid active pharmaceutical ingredient (API) manufacturing facility in Boulder, Colo. Agilent's Nucleic Acids Solutions Division is adding large-scale nucleic acid synthesis, ......
-
Cornell researchers study bacterium big enough to see
(08 May 2008)
The secret to an unusual bacterium's massive size - it's the size of a grain of salt, or a million times bigger than E. coli bacteria, and big enough to see with the naked eye - may be found in its ability to copy its genome tens of thousands ......
|
|
|
Top